CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,175,076 | +91.6% | 30,585 | +15.4% | 0.01% | +80.0% |
| Q1 2023 | $613,359 | -11.6% | 26,495 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $694,169 | +33.3% | 26,495 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $520,892 | +34.7% | 26,495 | +19.9% | 0.00% | +33.3% |
| Q2 2022 | $386,599 | +19.1% | 22,104 | +11.4% | 0.00% | +50.0% |
| Q1 2022 | $324,566 | +59.0% | 19,839 | +58.5% | 0.00% | 0.0% |
| Q4 2021 | $204,152 | +27.8% | 12,517 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $159,717 | -9.6% | 12,517 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $176,740 | +72.9% | 12,517 | +94.2% | 0.00% | +100.0% |
| Q4 2020 | $102,202 | – | 6,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |